Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78 | Cancer Immunity | journal | 1.345 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
77 | Current Pathobiology Reports | journal | 33 | 33 | 0 | 2872 | 0 | 0 | 0.00 | 87.03 | 37.65 | ||
76 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.738 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
75 | Hormones and Cancer | journal | 1.606 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
74 | Report on carcinogens. Monograph on .. | book series | 2 | 2 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | ||
73 | Advances in Cancer Research | journal | 4.017 Q1 | 109 | 29 | 71 | 6649 | 493 | 3 | 4.57 | 229.28 | 0.00 | |
72 | American Journal of Cancer Research (discontinued) | journal | 1.090 Q2 | 64 | 2 | 4 | 180 | 20 | 4 | 5.00 | 90.00 | 30.00 | |
71 | Cancer Therapy | journal | 0.136 Q4 | 9 | 9 | 23 | 419 | 14 | 23 | 2.00 | 46.56 | 41.38 | |
70 | National Toxicology Program technical report series | journal | 0.170 | 22 | 4 | 28 | 0 | 18 | 28 | 0.53 | 0.00 | 66.67 | |
69 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 28 | 749 | 0 | 28 | 0.00 | 187.25 | 0.00 | ||
68 | Cancer Immunology Research | journal | 134 | 68 | 30 | 787 | 112 | 29 | 2.10 | 11.57 | 35.21 | ||
67 | Oncogenesis | journal | 0.765 Q3 | 67 | 45 | 34 | 2105 | 45 | 33 | 1.32 | 46.78 | 41.74 | |
66 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 13 | 35 | 1797 | 126 | 35 | 3.71 | 138.23 | 47.46 | ||
65 | Annals of Cancer Research and Therapy | journal | 0.115 Q4 | 7 | 5 | 37 | 95 | 5 | 37 | 0.09 | 19.00 | 12.50 | |
64 | Critical Reviews in Oncogenesis | journal | 2.707 Q1 | 57 | 40 | 52 | 4229 | 264 | 45 | 5.08 | 105.73 | 35.05 | |
63 | Current Problems in Cancer | journal | 0.659 Q3 | 47 | 30 | 78 | 1853 | 94 | 58 | 0.64 | 61.77 | 50.00 | |
62 | Current Cancer Research | book series | 0.164 Q4 | 8 | 0 | 65 | 0 | 24 | 62 | 0.37 | 0.00 | 0.00 | |
61 | Drug Resistance Updates | journal | 3.734 Q1 | 132 | 10 | 72 | 1170 | 828 | 67 | 10.58 | 117.00 | 34.88 | |
60 | Journal of Experimental Therapeutics and Oncology | journal | 0.501 Q3 | 40 | 11 | 74 | 158 | 100 | 69 | 1.39 | 14.36 | 29.63 | |
59 | Journal of Mammary Gland Biology and Neoplasia | journal | 3.266 Q1 | 112 | 35 | 99 | 2675 | 694 | 89 | 4.83 | 76.43 | 60.81 | |
58 | Journal of the National Cancer Institute. Monographs | journal | 1.912 Q1 | 95 | 29 | 111 | 1342 | 422 | 101 | 2.46 | 46.28 | 53.52 | |
57 | Current Hematologic Malignancy Reports | journal | 1.228 Q2 | 44 | 45 | 105 | 2875 | 276 | 103 | 2.93 | 63.89 | 39.80 | |
56 | Seminars in Radiation Oncology | journal | 2.383 Q1 | 103 | 39 | 115 | 2195 | 516 | 103 | 4.13 | 56.28 | 26.51 | |
55 | Oncology Research | journal | 0.600 Q3 | 76 | 67 | 116 | 2001 | 197 | 116 | 1.62 | 29.87 | 31.44 | |
54 | American Journal of Translational Research (discontinued) | journal | 1.822 Q2 | 80 | 57 | 123 | 2718 | 565 | 121 | 4.48 | 47.68 | 33.53 | |
53 | Cancer cytopathology | journal | 1.589 Q2 | 68 | 114 | 184 | 2755 | 560 | 144 | 2.85 | 24.17 | 43.17 | |
52 | Translational Oncology | journal | 1.296 Q2 | 72 | 86 | 148 | 3659 | 488 | 148 | 2.98 | 42.55 | 36.98 | |
51 | Seminars in Cancer Biology | journal | 5.110 Q1 | 179 | 66 | 165 | 6712 | 1519 | 149 | 9.56 | 101.70 | 39.67 | |
50 | Recent Results in Cancer Research | book series | 1.153 Q2 | 63 | 74 | 171 | 5200 | 533 | 163 | 3.09 | 70.27 | 29.11 | |
49 | Journal of Cancer Science and Therapy (discontinued) | journal | 0.158 Q4 | 22 | 78 | 187 | 3112 | 84 | 171 | 0.39 | 39.90 | 35.11 | |
48 | Clinical Lung Cancer | journal | 1.260 Q2 | 74 | 100 | 181 | 3660 | 566 | 173 | 3.66 | 36.60 | 28.86 | |
47 | Cancer genetics | journal | 1.060 Q3 | 52 | 57 | 191 | 2196 | 467 | 181 | 2.45 | 38.53 | 52.96 | |
46 | Technology in Cancer Research and Treatment | journal | 0.785 Q3 | 72 | 60 | 193 | 1870 | 500 | 182 | 2.22 | 31.17 | 31.30 | |
45 | Sub-Cellular Biochemistry | journal | 1.493 Q2 | 81 | 89 | 199 | 8974 | 470 | 195 | 1.73 | 100.83 | 37.89 | |
44 | Melanoma Research | journal | 1.113 Q2 | 80 | 75 | 216 | 2162 | 537 | 201 | 2.29 | 28.83 | 44.87 | |
43 | Clinical Breast Cancer | journal | 1.135 Q2 | 80 | 72 | 218 | 2481 | 617 | 203 | 3.07 | 34.46 | 43.94 | |
42 | Cancer Genetics and Cytogenetics | journal | 0.900 Q3 | 78 | 0 | 246 | 0 | 490 | 210 | 0.00 | 0.00 | 0.00 | |
41 | Nitric Oxide - Biology and Chemistry | journal | 1.181 Q2 | 110 | 83 | 242 | 4156 | 908 | 229 | 3.46 | 50.07 | 45.19 | |
40 | European Journal of Cancer Prevention | journal | 1.076 Q2 | 88 | 90 | 241 | 2904 | 678 | 230 | 2.89 | 32.27 | 45.12 | |
39 | Cancer journal (Sudbury, Mass.) | journal | 102 | 74 | 261 | 4493 | 1132 | 234 | 4.06 | 60.72 | 39.44 | ||
38 | Journal of Immunotherapy | journal | 1.802 Q2 | 106 | 55 | 248 | 2209 | 1035 | 243 | 3.99 | 40.16 | 43.07 | |
37 | Stem Cell Reviews and Reports | journal | 1.565 Q2 | 87 | 75 | 262 | 4974 | 1273 | 260 | 4.98 | 66.32 | 42.61 | |
36 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.592 Q3 | 68 | 98 | 272 | 3422 | 512 | 262 | 1.68 | 34.92 | 39.61 | |
35 | Genes and Cancer | journal | 3.104 Q1 | 81 | 53 | 277 | 3918 | 1387 | 265 | 4.38 | 73.92 | 35.27 | |
34 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.797 Q3 | 65 | 151 | 296 | 4365 | 608 | 285 | 2.16 | 28.91 | 41.05 | |
33 | Molecular Imaging and Biology | journal | 1.067 Q3 | 78 | 90 | 313 | 2949 | 1081 | 303 | 3.40 | 32.77 | 31.05 | |
32 | Molecular Carcinogenesis | journal | 1.761 Q2 | 107 | 113 | 313 | 4847 | 1299 | 310 | 4.11 | 42.89 | 41.49 | |
31 | Current Opinion in Oncology | journal | 1.850 Q1 | 104 | 110 | 334 | 4939 | 1379 | 313 | 4.17 | 44.90 | 32.37 | |
30 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 1.005 Q3 | 90 | 129 | 335 | 3929 | 827 | 318 | 2.26 | 30.46 | 31.23 | |
29 | Cancer Investigation | journal | 1.087 Q2 | 93 | 82 | 325 | 3293 | 789 | 318 | 2.38 | 40.16 | 36.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®